About 30 Mg Paclitaxel Injection IP
Experience unrivaled efficacy with Paclitaxel Injection IP, 30 mg, now available at a superb promotion and price cut for distributors, suppliers, and exporters across India. This cost-effective antineoplastic agent meets immaculate IP regulatory standards for quality and consistency. Presented as a clear to slightly yellow solution in a glass vial, it is indicated for the treatment of breast, ovarian, and lung cancer in adults through intravenous administration. With a shelf life of 24 months and superior packaging, Paclitaxel Injection IP assures safety, potency, and optimal results.
Competitive Advantages and Applications
30 Mg Paclitaxel Injection IP offers superb therapeutic results in oncology, providing a cost-effective option without compromising quality. Suitable for adult cancer patients, it excels in treating breast, ovarian, and lung cancer. Its immaculate formulation ensures consistent dosing and reliable efficacy, meeting IP standards. The product's clear to slightly yellow solution guarantees purity, making it an unrivaled choice for clinicians seeking a trusted intravenous chemotherapeutic agent for their patients.
Payment Terms, Sample Policy, and Export Markets
Our asking price for 30 Mg Paclitaxel Injection IP is highly competitive, adding value for distributors and traders. Logistics are streamlined for efficient export, with prompt delivery across major markets including Asia, Africa, and the Middle East. Sample policy is flexible, allowing buyers to evaluate the product's quality at a favorable rate. Payment terms are designed to facilitate smooth transactions, ensuring satisfaction for both exporters and suppliers.
FAQ's of 30 Mg Paclitaxel Injection IP:
Q: How is Paclitaxel Injection IP administered?
A: Paclitaxel Injection IP, 30 mg, is administered intravenously by a healthcare professional, with dosage as directed by the physician.
Q: What are the main indications for using Paclitaxel Injection IP?
A: This injection is indicated for the treatment of breast cancer, ovarian cancer, and lung cancer in adult patients.
Q: When should Paclitaxel Injection IP not be used?
A: Paclitaxel Injection IP is contraindicated in patients who have hypersensitivity to paclitaxel or any formulation excipients.
Q: Where can Paclitaxel Injection IP be stored safely?
A: Store Paclitaxel Injection IP below 25C, protected from light, in its original carton box to maintain stability.
Q: What is the process for ordering and receiving samples?
A: Distributors and traders can request product samples at a favorable rate, with logistics arranged to ensure quick and secure delivery for evaluation.
Q: What are the benefits of choosing Paclitaxel Injection IP?
A: Benefits include cost-effective pricing, immaculate formulation standards, superior efficacy in treating several cancers, and compliance with IP regulations.